2023 international evidence-based guideline pcos glp-1 receptor agonist Frontiers Expanding therapeutic horizons: glucagon-like peptide-1
Description
in ELIXA, also hospital admission for unstable angina)
Check the availability updates page for the latest status
Consequently, further investigation is required to contextualize findings generated from oral GLP-1 agonists
*Correspondence: Mohammed Mahmmoud Fadelallah Eljack, [email protected] ORCID: Bisma Fatima Hammad, orcid.org/0000-0001-5558-3889
Injection sites: Three primary sites work for subcutaneous delivery
An identical study undertaken across 6 countries evaluated the tolerability of GLP-1 agonists in pregnant women and their effects on fetal outcomes (91)
